Dr Matthew Robert Hughes, MD - Medicare Colorectal Surgery (proctology) in Plano, TX

Dr Matthew Robert Hughes, MD is a medicare enrolled "Colon & Rectal Surgery" physician in Plano, Texas. He went to University Of Texas Medical Branch At Galveston and graduated in 2007 and has 17 years of diverse experience with area of expertise as Colorectal Surgery (proctology). He is a member of the group practice Texas Oncology Pa and his current practice location is 6130 W Parker Rd Ste 112, Plano, Texas. You can reach out to his office (for appointments etc.) via phone at (469) 229-7479.

Dr Matthew Robert Hughes is licensed to practice in Texas (license number P4065) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013111889.

Contact Information

Dr Matthew Robert Hughes, MD
6130 W Parker Rd Ste 112,
Plano, TX 75093-7918
(469) 229-7479
(866) 644-6804



Physician's Profile

Full NameDr Matthew Robert Hughes
GenderMale
SpecialityColorectal Surgery (proctology)
Experience17 Years
Location6130 W Parker Rd Ste 112, Plano, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Matthew Robert Hughes attended and graduated from University Of Texas Medical Branch At Galveston in 2007
  NPI Data:
  • NPI Number: 1013111889
  • Provider Enumeration Date: 06/13/2007
  • Last Update Date: 03/17/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 7416196381
  • Enrollment ID: I20130626000028

Medical Identifiers

Medical identifiers for Dr Matthew Robert Hughes such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013111889NPI-NPPES
339068404MedicaidTX
339068403MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208600000XSurgery TRN#11220 (Florida)Secondary
208C00000XColon & Rectal Surgery P4065 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Baylor Scott & White Medical Center - FriscoFrisco, TXHospital
Texas Health Presbyterian Hospital PlanoPlano, TXHospital
Texas Health Presbyterian Hospital DallasDallas, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Texas Oncology Pa5395658934855

News Archive

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

HALO Ablation System shows great promise for precancerous esophagus disease

BARRX Medical, Inc. has announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system.

CDC report blames researcher's haste for bird flu virus mishandling

An investigation into the mistaken shipment of deadly bird flu virus from a government laboratory earlier this year found that a scientist took shortcuts to speed up the work and accidentally contaminated the samples, the Centers for Disease Control and Prevention reported Friday.

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Matthew Robert Hughes allows following entities to bill medicare on his behalf.
Entity NameTexas Oncology Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811944101
PECOS PAC ID: 5395658934
Enrollment ID: O20031124000323

News Archive

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

HALO Ablation System shows great promise for precancerous esophagus disease

BARRX Medical, Inc. has announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system.

CDC report blames researcher's haste for bird flu virus mishandling

An investigation into the mistaken shipment of deadly bird flu virus from a government laboratory earlier this year found that a scientist took shortcuts to speed up the work and accidentally contaminated the samples, the Centers for Disease Control and Prevention reported Friday.

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

Read more Medical News

› Verified 4 days ago

Entity NameTexas Colon & Rectal Surgeons, Llp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487693834
PECOS PAC ID: 1557345063
Enrollment ID: O20040614001021

News Archive

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

HALO Ablation System shows great promise for precancerous esophagus disease

BARRX Medical, Inc. has announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system.

CDC report blames researcher's haste for bird flu virus mishandling

An investigation into the mistaken shipment of deadly bird flu virus from a government laboratory earlier this year found that a scientist took shortcuts to speed up the work and accidentally contaminated the samples, the Centers for Disease Control and Prevention reported Friday.

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Matthew Robert Hughes is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Matthew Robert Hughes, MD
1732 Bluffview Ln,
Carrollton, TX 75007-1426

Ph: (972) 210-9952
Dr Matthew Robert Hughes, MD
6130 W Parker Rd Ste 112,
Plano, TX 75093-7918

Ph: (469) 229-7479

News Archive

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

HALO Ablation System shows great promise for precancerous esophagus disease

BARRX Medical, Inc. has announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system.

CDC report blames researcher's haste for bird flu virus mishandling

An investigation into the mistaken shipment of deadly bird flu virus from a government laboratory earlier this year found that a scientist took shortcuts to speed up the work and accidentally contaminated the samples, the Centers for Disease Control and Prevention reported Friday.

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

Read more News

› Verified 4 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.